1394129-94-2 Usage
Uses
Used in Pharmaceutical Synthesis:
Methyl 3,3-difluorocyclopentanecarboxylate is used as a building block for the synthesis of pharmaceuticals, leveraging its ability to introduce the difluoromethyl group into organic molecules, which can enhance the biological activity and pharmacokinetic properties of the resulting compounds.
Used in Agrochemical Synthesis:
In the agrochemical industry, Methyl 3,3-difluorocyclopentanecarboxylate is employed as a versatile intermediate for the development of new agrochemicals, contributing to the creation of more effective and environmentally friendly products.
Used in Organic Synthesis:
Methyl 3,3-difluorocyclopentanecarboxylate is utilized as a valuable intermediate in organic synthesis, enabling the introduction of the difluoromethyl group into a wide range of organic molecules, thereby expanding the scope of chemical reactions and the synthesis of novel compounds.
Used in Medicinal Chemistry:
As a precursor in the preparation of fluorinated cyclopentane derivatives, Methyl 3,3-difluorocyclopentanecarboxylate is used in medicinal chemistry to explore the potential applications of these derivatives in drug discovery and development.
Used in Material Science:
Methyl 3,3-difluorocyclopentanecarboxylate is also employed in material science for the synthesis of fluorinated cyclopentane derivatives, which may possess unique properties that can be harnessed in the development of advanced materials with specific applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1394129-94-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,4,1,2 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1394129-94:
(9*1)+(8*3)+(7*9)+(6*4)+(5*1)+(4*2)+(3*9)+(2*9)+(1*4)=182
182 % 10 = 2
So 1394129-94-2 is a valid CAS Registry Number.
1394129-94-2Relevant academic research and scientific papers
Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes
-
, (2015/07/07)
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) as follows: wherein R1, G, and Q are defined herein.
ISOTHIAZOLE DERIVATIVES AS GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
-
, (2015/11/02)
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) as follows: wherein R1, G, and Q are defined herein.
GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
-
, (2014/09/30)
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) and Formula (II) as follows: wherein Y, R1, G, and Q are defined herein; and wherein R11, R21, R41, RB1 and G1, are defined herein.
